RA CAPITAL MANAGEMENT, L.P.
CIK 1346824 · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.09B
Companies
44
Total Filings
98
Lifetime Open-Market Net
-$102.39B
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NKTX | Director | 2,271,796 | $2.86 | $6.50M | $180.00M | 2 | 2026-06-11 |
| BCAX | Director | — | $21.69 | — | $0 | 1 | 2026-06-10 |
| COAG | 10%+ Owner | 6,375,972 | — | — | $479.1K | 1 | 2026-05-21 |
| ACET | 10%+ Owner | 1,033,605 | $8.05 | $8.32M | $6.42M | 1 | 2026-04-13 |
| WVE | Director | 23,157,567 | $5.87 | $135.93M | $328.50M | 5 | 2026-03-30 |
| Climb Bio, Inc. (ELYM) Delisted | Director | 2,866,375 | $5.11 | $14.65M | $174.2K | 1 | 2026-01-07 |
| SION | Director | 661,019 | $35.92 | $23.74M | $114.30M | 2 | 2025-11-24 |
| MLYS | Director | 1,867,229 | $23.62 | $44.10M | $150.00M | 3 | 2025-09-08 |
| SEPN | Director | — | $35.95 | — | $0 | 1 | 2025-06-20 |
| Cidara Therapeutics, Inc. (CDTX) Delisted | Director | — | $221.38 | — | $0 | 1 | 2025-06-18 |
| TYRA | Director | 442,721 | $26.99 | $11.95M | $9.52M | 2 | 2025-06-11 |
| VOR | Director | 8,539,921 | $14.36 | $122.63M | $214.53M | 4 | 2025-05-23 |
| SLDB | Director | 4,192,216 | $7.14 | $29.93M | $25.00M | 3 | 2025-02-21 |
| ANTX | 10%+ Owner | 1,725,348 | $4.74 | $8.18M | $105.98M | 3 | 2024-08-13 |
| SPRY | Director | 2,106,774 | $9.76 | $20.56M | $0 | 2 | 2024-06-24 |
| ABOS | Director | — | $2.37 | — | $0 | 3 | 2024-06-10 |
| BOLD | 10%+ Owner | 1,587,912 | $1.41 | $2.24M | $25.00M | 1 | 2024-04-04 |
| HOWL | Director | — | $0.38 | — | $0 | 2 | 2023-06-23 |
| Icosavax, Inc. (ICVX) Delisted | Director | — | $15.31 | — | $0 | 1 | 2023-06-08 |
| DICE Therapeutics, Inc. (DICE) Delisted | Director | 786,407 | $47.55 | $37.39M | $141.28M | 3 | 2023-03-30 |
| IMRA | 10%+ Owner | 3,880,021 | $17.02 | $66.04M | $10.06M | 1 | 2023-01-05 |
| FULC | 10%+ Owner | 7,824,600 | $3.45 | $26.99M | $52.30M | 1 | 2022-12-16 |
| JANX | Director | — | $13.56 | — | $0 | 1 | 2022-06-16 |
| iTeos Therapeutics, Inc. (ITOS) Delisted | Director | 3,155,667 | $10.15 | $32.03M | $0 | 2 | 2022-06-10 |
| Forma Therapeutics Holdings, Inc. (FMTX) Delisted | Director | 1,511,425 | $20.01 | $30.24M | $0 | 1 | 2022-06-09 |
| KALA | Director | 7,039,613 | $2.63 | $18.51M | $16.58M | 4 | 2022-05-26 |
| PEPG | Director | 1,052,851 | $1.47 | $1.55M | $193.75M | 2 | 2022-05-12 |
| Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Director | 4,681,858 | $1.10 | $5.15M | $60.00M | 2 | 2020-12-07 |
| RYTM | 4,568,464 | $88.38 | $403.76M | -$28.12M | 1 | 2020-12-04 | |
| PMVP | 10%+ Owner | 1,710,265 | $1.11 | $1.90M | $51.30M | 1 | 2020-09-29 |
| VSTM | 10%+ Owner | 16,142,051 | $4.10 | $66.18M | -$8.88M | 1 | 2020-06-29 |
| PHAT | 10%+ Owner | 3,707,408 | $10.37 | $38.45M | $5.96M | 1 | 2020-03-31 |
| Synthorx, Inc. (THOR) Delisted | 10%+ Owner | 0 | — | — | $100.00M | 2 | 2020-01-24 |
| Ra Pharmaceuticals, Inc. (RARX) Delisted | Director | 4,858,260 | — | — | $98.10M | 5 | 2019-06-13 |
| ARVN | 3,138,412 | $7.58 | $23.79M | $48.00M | 1 | 2018-10-03 | |
| KALV | Director | 591,070 | $27.00 | $15.96M | $0 | 1 | 2016-11-23 |
| ACRS | 10%+ Owner | 2,469,552 | $4.32 | $10.67M | $59.06M | 3 | 2015-10-30 |
| SANGAMO THERAPEUTICS, INC (SGMO) Delisted | 2,829,441 | $0.18 | $502.5K | -$82.39M | 2 | 2015-02-18 | |
| ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | 10%+ Owner | 9,700,000 | — | — | -$104.29B | 8 | 2014-09-26 |
| DERMA SCIENCES, INC. (DSCI) Delisted | 1,884,876 | — | — | -$10.65M | 1 | 2014-01-13 | |
| BIOSPECIFICS TECHNOLOGIES CORP (BSTC) Delisted | 10%+ Owner | 626,462 | — | — | -$3.54M | 6 | 2010-02-26 |
| SEQUENOM INC (SQNM) Delisted | 10%+ Owner | 5,506,093 | — | — | $28.98M | 3 | 2008-07-15 |
| LIPID SCIENCES INC/ (LIPD) Delisted | 10%+ Owner | 3,705,312 | — | — | -$56.2K | 1 | 2008-03-31 |
| ARADIGM CORP (ARDM) Delisted | 10%+ Owner | 7,489,810 | — | — | $5.21M | 2 | 2007-11-05 |
Recent Filings · Page 4 of 10
98 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-03-30 | DICE Therapeutics, Inc. (DICE) Delisted | Buy (P) | +2,545,725 | $73.99M | EDGAR |
| 2023-03-27 | DICE Therapeutics, Inc. (DICE) Delisted | Buy (P) | +2,492,780 | $67.29M | EDGAR |
| 2023-01-05 | IMRA | Buy (P) | +2,517,188 | $10.06M | EDGAR |
| 2022-12-16 | FULC | Buy (P) | +9,612,196 | $52.30M | EDGAR |
| 2022-12-05 | SLDB | Grant (A) | +12,865,965 | $76.25M | EDGAR |
| 2022-11-10 | SPRY | Grant (A) | +15,048,390 | $0 | EDGAR |
| 2022-06-23 | ANTX | Buy (P) | +1,510 | $12.1K | EDGAR |
| 2022-06-21 | ABOS | Grant (A) | — | $0 | EDGAR |
| 2022-06-17 | VOR | Grant (A) | — | $0 | EDGAR |
| 2022-06-16 | JANX | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.